Company Description:
Caravel Autism Health is a leading provider of comprehensive Applied Behavioral Analysis (“ABA”) therapy, serving the needs of individuals with Autism Spectrum Disorder (“ASD”) and their families. Caravel’s team of experienced therapists and Board-Certified Behavior Analysts (“BCBAs”) are dedicated to superior clinical outcomes, delivering home-based treatment programs consistent with each child’s personalized and data-driven treatment plan. Led by a highly passionate management team, Caravel has established itself as a premier provider of ABA therapy services in the Upper Midwest.
Objectives:
TripleTree was selected by Caravel as its exclusive financial advisor based on deep healthcare services knowledge and behavioral health expertise, including specific experience in autism health. TripleTree assisted the Company in determining the optimal time for a strategic investment amidst rapid growth and implementation of key operational initiatives, and ultimately evaluating and selecting the right financial partner for its next phase of growth. TripleTree strategically positioned the Company by highlighting their unique set of competencies that differentiated Caravel from a highly fragmented and rapidly emerging marketplace.
Results:
Caravel received a strategic investment from Frazier Healthcare Partners following engaged discussions with a number of distinguished private equity firms that brought depth and expertise in helping grow highly successful healthcare services companies. The partnership combines Frazier’s focused healthcare experience and track-record in supporting best-in-class, multi-site healthcare services platforms with Caravel’s innovative approach to serving the rapidly escalating demands of autism health. The investment will further accelerate the company’s dedicated efforts to advance clinical standards within autism while continuing Caravel’s geographic and care delivery model expansion.
Read full press release from Caravel Autism Health.
Read full press release from TripleTree.